
    
      Methods: A randomized double-blind study was carried out in women with GDM. Patients were
      randomly exposed to inositol and placebo. Increase of BMI, blood glucose at 75 grams oral
      glucose tolerance test (OGTT), fetal and neonatal adverse outcome, and insulin treatment were
      correlated to inositol exposure.
    
  